Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Int Arch Allergy Immunol ; 171(1): 36-44, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27820933

RESUMEN

BACKGROUND: Secretoglobin (SCGB) 3A2, a novel, lung-enriched, cytokine-like, secreted protein of small molecular weight, was demonstrated to exhibit various biological functions including anti-inflammatory, antifibrotic and growth-factor activities. Anti-inflammatory activity was uncovered using the ovalbumin-induced allergic airway inflammation model. However, further validation of this activity using knockout mice in a different allergic inflammation model is necessary in order to establish the antiallergic inflammatory role for this protein. METHODS: Scgb3a2-null (Scgb3a2-/-) mice were subjected to nasal inhalation of Dermatophagoides pteronyssinus extract for 5 days/week for 5 consecutive weeks; control mice received nasal inhalation of saline as a comparator. Airway inflammation was assessed by histological analysis, the number of inflammatory cells and various Th2-type cytokine levels in the lungs and bronchoalveolar lavage fluids by qRT-PCR and ELISA, respectively. RESULTS: Exacerbated inflammation was found in the airway of Scgb3a2-/- mice subjected to house dust mite (HDM)-induced allergic airway inflammation compared with saline-treated control groups. All the inflammation end points were increased in the Scgb3a2-/- mice. The Ccr4 and Ccl17 mRNA levels were higher in HDM-treated lungs of Scgb3a2-/- mice than wild-type mice or saline-treated Scgb3a2-/- mice, whereas no changes were observed for Ccr3 and Ccl11 mRNA levels. CONCLUSIONS: These results demonstrate that SCGB3A2 has an anti-inflammatory activity in the HDM-induced allergic airway inflammation model, in which SCGB3A2 may modulate the CCR4-CCL17 pathway. SCGB3A2 may provide a useful tool to treat allergic airway inflammation, and further studies on the levels and function of SCGB3A2 in asthmatic patients are warranted.


Asunto(s)
Alérgenos/inmunología , Hipersensibilidad/inmunología , Hipersensibilidad/metabolismo , Pyroglyphidae/inmunología , Secretoglobinas/metabolismo , Animales , Líquido del Lavado Bronquioalveolar/citología , Líquido del Lavado Bronquioalveolar/inmunología , Citocinas/metabolismo , Modelos Animales de Enfermedad , Femenino , Hipersensibilidad/genética , Hipersensibilidad/patología , Ratones , Ratones Noqueados , Secretoglobinas/genética
2.
Mol Cancer ; 11: 90, 2012 Dec 12.
Artículo en Inglés | MEDLINE | ID: mdl-23234329

RESUMEN

BACKGROUND: The CCAAT/enhancer binding proteins (C/EBPs) play important roles in carcinogenesis of many tumors including the lung. Since multiple C/EBPs are expressed in lung, the combinatorial expression of these C/EBPs on lung carcinogenesis is not known. METHODS: A transgenic mouse line expressing a dominant negative A-C/EBP under the promoter of lung epithelial Clara cell secretory protein (CCSP) gene in doxycycline dependent fashion was subjected to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung carcinogenesis bioassay in the presence and absence of doxycycline, and the effect of abolition of DNA binding activities of C/EBPs on lung carcinogenesis was examined. RESULTS: A-C/EBP expression was found not to interfere with tumor development; however, it suppressed the malignant conversion of adenoma to carcinoma during NNK-induced lung carcinogenesis. The results suggested that Ki67 may be used as a marker for lung carcinomas in mouse. CONCLUSIONS: The DNA binding of C/EBP family members can be used as a potential molecular target for lung cancer therapy.


Asunto(s)
Adenoma/genética , Proteínas Potenciadoras de Unión a CCAAT/deficiencia , Carcinoma/genética , Transformación Celular Neoplásica/genética , Neoplasias Pulmonares/genética , Adenoma/epidemiología , Adenoma/patología , Animales , Biomarcadores de Tumor/metabolismo , Proteínas Potenciadoras de Unión a CCAAT/genética , Proteínas Potenciadoras de Unión a CCAAT/metabolismo , Carcinoma/epidemiología , Carcinoma/patología , Transformación Celular Neoplásica/inducido químicamente , Etiquetado Corte-Fin in Situ , Incidencia , Antígeno Ki-67/metabolismo , Neoplasias Pulmonares/inducido químicamente , Neoplasias Pulmonares/epidemiología , Neoplasias Pulmonares/patología , Masculino , Ratones , Ratones Transgénicos , Nitrosaminas/toxicidad , Alveolos Pulmonares/patología
4.
Carcinogenesis ; 30(9): 1614-9, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19581346

RESUMEN

NKX2-1 is a homeodomain transcription factor that is critical for genesis of the thyroid and transcription of the thyroid-specific genes. Nkx2-1-thyroid-conditional hypomorphic mice were previously developed in which Nkx2-1 gene expression is lost in 50% of the thyroid cells. Using this mouse line as compared with wild-type and Nkx2-1 heterozygous mice, a thyroid carcinogenesis study was carried out using the genotoxic carcinogen N-bis(2-hydroxypropyl)-nitrosamine (DHPN), followed by sulfadimethoxine (SDM) or the non-genotoxic carcinogen amitrole (3-amino-1,2,4-triazole). A significantly higher incidence of adenomas was obtained in Nkx2-1-thyroid-conditional hypomorphic mice as compared with the other two groups of mice only when they were treated with DHPN + SDM, but not amitrole. A bromodeoxyuridine incorporation study revealed that thyroids of the Nkx2-1-thyroid-conditional hypomorphic mice had >2-fold higher constitutive cell proliferation rate than the other two groups of mice, suggesting that this may be at least partially responsible for the increased incidence of adenoma in this mouse line after genotoxic carcinogen exposure. Thus, NKX2-1 may function to control the proliferation of thyroid follicular cells following damage by a genotoxic carcinogen.


Asunto(s)
Adenoma/inducido químicamente , Carcinógenos/toxicidad , Nitrosaminas/toxicidad , Proteínas Nucleares/fisiología , Neoplasias de la Tiroides/inducido químicamente , Factores de Transcripción/fisiología , Amitrol (Herbicida)/toxicidad , Animales , Femenino , Genes ras , Hiperplasia , Masculino , Ratones , Hipófisis/patología , Sulfadimetoxina/toxicidad , Factor Nuclear Tiroideo 1
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA